Drug targeting to the kidney: Advances in the active targeting of therapeutics to proximal tubular cells☆
M. Emmy M. Dolman(Cancer Institute of New South Wales), Robbert J. Kok(Utrecht University), Wim E. Hennink(Utrecht University), Stefan Harmsen(Utrecht University), G. Storm(Utrecht University)
Cited by 153
Related Papers
Tumour-targeted nanomedicines: principles and practice
|British Journal of Cancer|2008|535
RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature
|Drug Resistance Updates|2005|461
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
|Advanced Drug Delivery Reviews|2013|396
Diverse origins of the myofibroblast—implications for kidney fibrosis
|Nature Reviews Nephrology|2015|305
Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: State-of-the-art and challenges
|International Journal of Pharmaceutics|2016|285